Sign in Check my fit
EN
Home / Horizon Europe / HORIZON-MISS-2026-05-SOIL-02

Antimicrobial resistance and antibiotic biosynthesis in soils: developing key understanding and counteractive strategies using a One-Health approach

Open now · HORIZON Research and Innovation Actions · HORIZON-MISS-2026-05-SOIL-02

Next cut-off
23 Sept '26
in 17 days
Per grant
€7.0M
the call's own average
Grants expected
2
projects that will be funded
Funding rate
100%
the full cost of the action

In context of Horizon Europe

This grant€7.0M
The track runs to the largest grant in Horizon Europe (€171M). The median across the 482 calls we publish is €5.3M, this one is above it.

What this call funds

Expected Outcome:

Activities under this topic will help progress towards the objectives and targets of the Mission Soil and of the EU Soil Strategy for 2030, the Zero Pollution Action Plan, the European One Health Action Plan against antimicrobial resistance as well as the Sustainable Development Goals[1].

Project results are expected to contribute to all the following expected outcomes:

  • policymakers, land managers and other relevant stakeholders have an enhanced understanding of antimicrobial resistance development in soils, the key drivers and pathways of soil’s contribution to human and animal exposure to antimicrobial resistant genes and organisms, as well as antibiotic biosynthesis in soils;
  • policymakers and land managers have increased access and capacity to implement evidence-based strategies aimed at reducing the risk of antimicrobial resistance development in soils and minimising the exposure of humans and animals to antimicrobial resistant genes and organisms;
  • policymakers and other relevant stakeholders benefit from improved access to enriched databases of antibiotics-related genes and antibiotic alternatives from soil microorganisms;
  • citizens are more aware of the importance of soil and soil biodiversity for human, animal and environmental health as well as on their potential as a source of molecules of interest for pharmaceutical purposes.

Scope:

Trimmed here, the full scope, expected outcomes and award criteria are on the official topic page ↗.

What applying costs you

ItemEstimateNote
Drafting effort6–8 weekssingle submission
Partner search4–8 weeksruns in parallel, and it is the part that slips
Time to first payment6–9 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Where these conditions come from

Two kinds of row. Most are the sentence we read the condition from, quoted out of the call itself. Some say plainly that they are not a quotation but the programme's own rule for this type of action, the EU portal publishes a table of contents where the conditions should be, so for a Research and Innovation Action the rate comes from the rulebook rather than from the fiche.

ConditionQuoted from the call, or the rule behind it
Consortium sizeNot quoted from this call — Research and Innovation Actions under the Horizon Europe rules are at least three independent legal entities from three different Member States or Associated Countries, at least one established in a Member State.
Funding rateNot quoted from this call — Research and Innovation Actions under the Horizon Europe rules are funded at 100% of eligible costs for every participant.

Also open in HE

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit